Fig 1.
Design of the four randomised, placebo-controlled trials of tadalafil 5mg once daily in patients with LUTS-BPH.
Table 1.
Baseline characteristics of the ITT population used for data mining analysis.
Table 2.
Definition of treatment response on the IPSS, BII and PGI-I after 12 weeks treatment with tadalafil or placebo as used in the clinical data mining analysis.
Fig 2.
Data Analysis Flow.
Table 3.
Primary results for both treatment groups.
Table 4.
Secondary Results (Tadalafil 5mg once daily).
Table 5.
Secondary Results (Placebo).
Table 6.
Exploratory Results.